Caesars Entertainment Corp (NASDAQ:CZR) traded 2,962,917 shares on last trading session with closing price of $9.60.
CZR was trading -11.44% below its 52-week high and 78.11% above its 52-week low. Its last 5-Year EPS growth stands at -51.20%; with earnings growth of -135.90% yoy. The stock stands 2.62% above the average-price of 50 days and 1.19% compared with the SMA 20.
The stock has a 1-year performance up 29.03% and a positive weekly performance at 0.52%. Moreover, the stock is up 1.59% in one month through last close, to $9.60, showing a 7.26% return during the past three months. The company is set at a mean analysts’ recommendation of 3.00.
Baxter International Inc (NYSE:BAX) shares moved to $52.89 after opening the day at $52.65, on Thursday. The stock floated in a price range of $52.38 to $52.94, with market capitalization of $28.65B. The stock exchanged hands with 2,998,282 shares higher as compared to its average daily volume of 2.93M shares. If we take a look on its volatility, 1.14 percent was seen in a week and for the month it was 1.14 percent.
Baxter International Inc. (BAX), a leader in innovative technology for medication delivery, recently declared a new, comprehensive guide to building a smart infusion system drug library.
Drug libraries assist clinicians identify potential infusion errors before they harm patients by checking the pump’s programming against a curated list of medications and fluids and their medically appropriate dose ranges. If programming exceeds drug library limits, smart pumps will alert clinicians.
“A carefully built drug library is critical for the safe and effective use of any smart infusion system. This publication guides comprehensive drug library development and integration with an electronic health record, and is designed to advance infusion safety in all hospitals regardless of infusion system,” said guide lead author, Tim Hoh, RPh, senior manager, Medical Affairs, Baxter.
Baxter incorporated input from ISMP into a tool intended to be used by the many diverse stakeholders within a hospital, counting the pharmacy team, nursing staff, prescribers and IT representatives, all of whom serve crucial roles on building and maintaining the drug library.
Baxter developed the guide based on real-world experience assisting to build drug libraries for thousands of healthcare facilities that use the Sigma Spectrum Infusion System, which has resulted in hospitals achieving an average 97 percent drug library compliance rate within the first month of implementation.
The company’s net profit margin stands at 48.90% whereas its return on equity (ROE) is 57.60%. It has 541.96M of outstanding shares and its shares float measured at 541.41M. The average analysts gave this company a mean recommendation of 2.70.